EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current understanding and clinical management of congenital melanocytic naevi: a review

Zeyu Liu iD, Mingyuan Xu iD, Jiashe Chen, Wei Tan, Xiaoxiang Xu, Yeqiang Liu iD

Clinical and Experimental Dermatology · 28.05.2026

DOI: 10.1093/ced/llag219 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 28.05.2026. Verfasst von Zeyu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Nevus, Pigmented, Skin Neoplasms. Die Arbeit nennt 77 Literaturangaben. Gefördert von: Tongji University 2025 "Medicine + X" Interdisciplinary Research Project, National Natural Science Foundation of China, Clinical Research Incubation Program of Shanghai Skin Disease Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital melanocytic naevi (CMN) are benign melanocytic proliferations originating from neural crest cells and presenting at birth or in early infancy with variable clinical manifestations and malignancy risks. The incidence of CMN varies by sex, with a higher prevalence in female patients but with potentially greater complications in male patients. Genetic studies have highlighted the pivotal role of mutations in BRAF and NRAS in influencing the size and malignancy risk of CMN. Diagnostic challenges necessitate a systematic approach, including histopathology, molecular profiling and risk-stratified therapeutic selection. This review synthesizes current knowledge on CMN epidemiology, molecular pathogenesis, diagnostic advancements and therapeutic strategies. Future directions emphasize the need for longitudinal studies to validate interventions, multidisciplinary collaboration and biomarker-driven personalized management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nevus, PigmentedSkin NeoplasmsHumansGTP PhosphohydrolasesMutationProto-Oncogene Proteins B-rafFemaleMembrane ProteinsMale

Substanzen

GTP PhosphohydrolasesProto-Oncogene Proteins B-rafNRAS protein, humanMembrane ProteinsBRAF protein, human

Autor:innen und Institutionen

  • Department of Pathology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Zeyu Liu, Mingyuan Xu, Yeqiang Liu

Förderung

  • Tongji University 2025 "Medicine + X" Interdisciplinary Research Project
  • National Natural Science Foundation of China
  • Clinical Research Incubation Program of Shanghai Skin Disease Hospital
  • Tongji University 2025 “Medicine + X” Interdisciplinary Research Project

Zitieren

APA

Liu, Z., Xu, M., Chen, J., Tan, W., Xu, X., & Liu, Y. (2026). Current understanding and clinical management of congenital melanocytic naevi: a review. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag219

Vancouver

Liu Z, Xu M, Chen J, Tan W, Xu X, Liu Y. Current understanding and clinical management of congenital melanocytic naevi: a review. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag219

BibTeX
@article{Liu2026,
  author = {Liu, Zeyu and Xu, Mingyuan and Chen, Jiashe and Tan, Wei and Xu, Xiaoxiang and Liu, Yeqiang},
  title = {Current understanding and clinical management of congenital melanocytic naevi: a review},
  journal = {Clinical and Experimental Dermatology},
  year = {2026},
  doi = {10.1093/ced/llag219}
}
Kostenlos starten →